S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)

Podobne zapisy

• S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
  od: M Elalfy, i wsp.
  Wydane: (2022-01-01)
• P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY
  od: Sherif Badawy, i wsp.
  Wydane: (2023-08-01)
• A decisional algorithm to start iron chelation in patients with beta thalassemia
  od: Fabrice Danjou, i wsp.
  Wydane: (2014-03-01)
• Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
  od: Khaled M. Musallam, i wsp.
  Wydane: (2011-02-01)
• Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
  od: Nargesbeygom Mirbehbahani, i wsp.
  Wydane: (2015-01-01)